Colgate-Palmolive (India) Ltd. share price target

Top takeaways from Q1FY17: Revenue growth at 12.5% yoy was ahead of our/street estimates.Volume growth at 6% yoy with domestic volume growth of 5% yoy was in line; pricing growth continued to be robust at 6% yoy. Market share in Tooth paste recovered 60bps qoq to 55.9%; Tooth brush share improved 100 bps qoq to 46.8%.Gross margins rose 240bps yoy and surprised positively. EBIDTA margins shrunk 160bps yoy on higher ad spends and EBITDA growth missed estimates.Phillip Capital value the company at 40x, FY18E earnings (35x earlier) at Rs 1110 (earlier Rs 960) and maintain Buy.

Trendlyne has 11 reports on COLPAL updated in the last year from 4 brokers with an average target of Rs 995.5. Brokers have a rating for COLPAL with 2 price downgrades,1 price upgrade in past 6 months and 1 upgrade,2 price upgrades in past 1 Year.

ICICI Securities Ltd | Retail Equity Research Colgate-Palmolive (CPIL) posted healthy topline growth led by strong 6% volume growth. Domestic volume growth was at 5% in the...

Net sales of Colgate Palmolive (India) grew 8.9% yoy to Rs10.1bn, while EBITDA growth was recorded at 3.6% and PBT (before exceptional items) increased by just 1.7% to Rs1.9bn in the quarter ended June 30, 2016. It reported overall volume growth of 6% with domestic volume growing by 5%. While gross sales growth was higher at 12.5%, net sales grew just 8.9% on account of sharp 49% jump in tax outgo resulting from phasing out of Excise Duties benefits. Going forward, we estimate the volume growth to pick up pace, especially with the launch of Cibaca Vedshakti in the naturals space at an attractive price point. However,...

Colgate-Palmolive (CLGT) posted net sales growth of 8.9% YoY (est. of 9.5%) to INR10.1b (Ind-AS). Adjusting for excise impact YoY, organic sales growth was 12.5% YoY, led by 6% volume growth, including exports and 5% domestic volume growth (est. of +4.5%; highest in the past five quarters), selective price increases and product mix changes. EBITDA was up 3.7% YoY (est. of +19.6%) to INR2.11b, mainly because of higher A&P; YoY, while Adj. PAT was up 1.3% YoY (est. of +20.8% YoY) to INR1.26b. Toothpaste market share improved 60bp sequentially to 55.9%, while...

ICICI Securities Ltd | Retail Equity Research Colgate-Palmolive's (CPIL) net sales grew by 6.8% YoY to | 1091.1 crore (I-direct estimate: | 1056.8 crore) on the back of 6% volume...

Revenue growth at 7% yoy percent was ahead of estimates. Organic revenue growth excluding phasing of excise duty benefits was a robust 13% yoy Volume growth at 6% yoy with Domestic volume growth of 4% yoy was ahead of...

Colgate Palmolive (India) has reported mixed set of numbers for 4QFY16. While its revenues came in at Rs10.9bn (5% ahead of our estimate of Rs10.4bn), EBITDA and net profit came in 14% & 18% below our estimate at Rs2.3bn & Rs1.5bn respectively, which can be attributed to higher A&P; spends. The Company's net sales (excluding the impact of phasing-out of Excise Duties) grew by 13%, while net profit increased 14% in 4QFY16. We expect the Company to post revenue and earnings CAGR of 12.7% & 12%, respectively through FY16-18E and revise our recommendation on the stock from HOLD to ACCUMULATE with a Target Price of Rs851....

While Colgate continues to be the market leader in both toothbrushes and toothpastes by a considerable margin, its dominance has once again been challenged this time by Patanjali. Past contenders have included Anchor, Pepsodent, and Oral B. Patanjali's...

While Colgate continues to be the market leader in both toothbrushes and toothpastes by a considerable margin, its dominance has once again been challenged this time by Patanjali. Past contenders have included Anchor, Pepsodent, and Oral B. Patanjali's...

Colgates 3QFY16 revenues grew by a mere 1.9% YoY to Rs 10.1bn (vs. estimate of Rs 10.6bn). Impacted by the toothpaste category slowdown and rising competition, Colgate?s volume growth cracked to ~1%. Revenue growth was 7% excluding the impact of excise benefit withdrawal in Himachal Pradesh.